Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Study Phase : Discovery Platform
Sponsor : AI Proteins
Deal Size : Undisclosed
Deal Type : Collaboration
Details : The collaboration aims to develop novel, oral biologic therapies for inflammatory diseases by leveraging Vivtex’s proprietary and extensively validated GI-ORIS™ screening and formulation technology to evaluate and enhance the oral bioavailability of ...
Brand Name : Undisclosed
Molecule Type : Large molecule
Upfront Cash : Undisclosed
January 18, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Immunology
Highest Development Status : Discovery Platform
Sponsor : AI Proteins
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?